-
公开(公告)号:US20210205321A1
公开(公告)日:2021-07-08
申请号:US15733535
申请日:2019-02-21
Applicant: The Scripps Research Institute
Inventor: Luke L. Lairson , Emily Chin , Arnab K. Chatterjee , Manoj Kumar , Ana Maria Gamo Albero , Hank Michael James Petrassi , Peter G. Schultz , Chenguang Yu , Junko Tamiya , William Vernier , Anil Gupta , Ramkumar Modukuri
IPC: A61K31/5365 , A61K31/501 , A61K31/536 , A61K31/506 , A61K45/06 , A61K9/00 , A61K9/127 , A61K47/68
Abstract: The invention provides compounds having STimulator of INterferon Genes (STING) agonistic bioactivity that can be used in the treatment of tumors in patients afflicted therewith. The compounds are of formula (I): as defined herein. Compounds for practice of a method of the invention can be delivered via oral delivery for systemic exposure, as well as delivered intratumorally. Antitumor therapy using a compound of formula (I) can further comprise administration of an effective dose of an immune-checkpoint targeting drug.
-
公开(公告)号:US20220024949A1
公开(公告)日:2022-01-27
申请号:US17449509
申请日:2021-09-30
Applicant: The Scripps Research Institute
Inventor: Phil Baran , Chao Li , Jie Wang , Amab K. Chatterjee , Manoj Kumar , Shan Yu , Kristen Johnson , Tian Qin , Ming Shang
Abstract: The invention is directed to methods of converting a carboxylic acid group in a compound, via a redox active ester, to a corresponding boronic ester by treatment with bis(pinacolato)diboron-alkyllithium complex in the presence of a ligand, a Ni(II) salt or a copper salt, and an Mg(II) salt, in the presence of an alkyllithium or a lithium hydroxide or alkoxide salt. The product pinacolato boronate ester can be cleaved to provide a boronic acid. The invention is also directed to methods of preparing various compounds of medical value comprising boronic acid groups, and to novel boronic-acid containing compounds of medicinal value, including an atorvastatin boronic acid analog, a vancomycin aglycone boronic acid analog, and boronic acid containing elastase inhibitors mCBK319, mCBK320, mCBK323, and RPX-7009.
-
公开(公告)号:US11161859B2
公开(公告)日:2021-11-02
申请号:US16495907
申请日:2018-03-14
Applicant: The Scripps Research Institute
Inventor: Phil Baran , Chao Li , Jie Wang , Arnab Kumar Chatterjee , Manoj Kumar , Shan Yu , Kristen Ann Johnson , Tian Qin , Ming Shang
Abstract: The invention is directed to methods of converting a carboxylic acid group in a compound, via a redox active ester, to a corresponding boronic ester by treatment with bis(pinacolato)diboron-alkyllithium complex in the presence of a ligand, a Ni(ll) salt or a copper salt, and an Mg(ll) salt, in the presence of an alkyllithium or a lithium hydroxide or alkoxide salt. The product pinacolato boronate ester can be cleaved to provide a boronic acid. The invention is also directed to methods of preparing various compounds of medical value comprising boronic acid groups, and to novel boronic-acid containing compounds of medicinal value, including an atorvastatin boronic acid analog, a vancomycin aglycone boronic acid analog, and boronic acid containing elastase inhibitors mCBK319, mCBK320, mCBK323, and RPX-7009.
-
公开(公告)号:US20200024290A1
公开(公告)日:2020-01-23
申请号:US16495907
申请日:2018-03-14
Applicant: The Scripps Research Institute
Inventor: Phil Baran , Chao Li , Jie Wang , Arnab Kumar Chatterjee , Manoj Kumar , Shan Yu , Kristen Ann Johnson , Tian Qin , Ming Shang
Abstract: The invention is directed to methods of converting a carboxylic acid group in a compound, via a redox active ester, to a corresponding boronic ester by treatment with bis(pinacolato)diboron-alkyllithium complex in the presence of a ligand, a Ni(11) salt or a copper salt, and an Mg(11) salt, in the presence of an alkyllithium or a lithium hydroxide or alkoxide salt. The product pinacolato boronate ester can be cleaved to provide a boronic acid. The invention is also directed to methods of preparing various compounds of medical value comprising boronic acid groups, and to novel boronic-acid containing compounds of medicinal value, including an atorvastatin boronic acid analog, a vancomycin aglycone boronic acid analog, and boronic acid containing elastase inhibitors mCBK319, mCBK320, mCBK323, and RPX-7009.
-
公开(公告)号:US11701364B2
公开(公告)日:2023-07-18
申请号:US15733535
申请日:2019-02-21
Applicant: The Scripps Research Institute
Inventor: Luke L. Lairson , Emily Chin , Arnab K. Chatterjee , Manoj Kumar , Ana Maria Gamo Albero , Hank Michael James Petrassi , Peter G. Schultz , Chenguang Yu , Junko Tamiya , William Vernier , Anil Gupta , Ramkumar Modukuri
IPC: A61K31/5365 , A61K9/19 , A61K9/127 , A61K31/501 , A61K31/506 , A61K31/536 , A61K45/06 , A61K47/68 , A61K9/00
CPC classification number: A61K31/5365 , A61K9/0019 , A61K9/0053 , A61K9/127 , A61K31/501 , A61K31/506 , A61K31/536 , A61K45/06 , A61K47/6803
Abstract: The invention provides compounds having STimulator of INterferon Genes (STING) agonistic bioactivity that can be used in the treatment of tumors in patients afflicted therewith. The compounds are of formula (I): as defined herein. Compounds for practice of a method of the invention can be delivered via oral delivery for systemic exposure, as well as delivered intratumorally. Antitumor therapy using a compound of formula (I) can further comprise administration of an effective dose of an immune-checkpoint targeting drug.
-
-
-
-